INDV FY 2019 Earnings — Indivior Pharmaceuticals Inc Revenue & Financial Results | Market Cap Arena

INDVIndivior Pharmaceuticals Inc

$4B

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$785M-18.2% YoY

Gross Profit

$645M82.2% margin

Operating Income

$178M22.7% margin

Net Income

$134M17.1% margin

EPS (Diluted)

$0.92

Cash Flow

Operating Cash Flow

$151M

Free Cash Flow

$144M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$1.4B

Stockholders' Equity

$209M

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$785M	$960M	-18.2%
Gross Profit	$645M	$825M	-21.8%
Operating Income	$178M	$317M	-43.9%
Net Income	$134M	$263M	-49.0%